메뉴 건너뛰기




Volumn 6, Issue , 2016, Pages

Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

EID: 84978906713     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29707     Document Type: Article
Times cited : (216)

References (60)
  • 1
    • 84929452695 scopus 로고    scopus 로고
    • Antimicrobial peptides and peptidomimetics-potent therapeutic allies for staphylococcal infections
    • Mohammad, H., Thangamani, S., Seleem, M. N. Antimicrobial peptides and peptidomimetics-potent therapeutic allies for staphylococcal infections. Current pharmaceutical design 21, 2073-2088 (2015).
    • (2015) Current Pharmaceutical Design , vol.21 , pp. 2073-2088
    • Mohammad, H.1    Thangamani, S.2    Seleem, M.N.3
  • 3
    • 77951224305 scopus 로고    scopus 로고
    • Chronic wounds and the medical biofilm paradigm
    • 48-50, 52-43
    • Wolcott, R. D. et al. Chronic wounds and the medical biofilm paradigm. Journal of wound care 19, 45-46, 48-50, 52-43 (2010).
    • (2010) Journal of Wound Care , vol.19 , pp. 45-46
    • Wolcott, R.D.1
  • 4
    • 2942522970 scopus 로고    scopus 로고
    • Paul-Ehrlich-Society for, C. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: Results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001
    • Kresken, M., Hafner, D., Schmitz, F. J., Wichelhaus, T. A., Paul-Ehrlich-Society for, C. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. International journal of antimicrobial agents 23, 577-581, doi: 10.1016/j. ijantimicag.2003.11.007 (2004).
    • (2004) International Journal of Antimicrobial Agents , vol.23 , pp. 577-581
    • Kresken, M.1    Hafner, D.2    Schmitz, F.J.3    Wichelhaus, T.A.4
  • 5
    • 48349087831 scopus 로고    scopus 로고
    • Antimicrobial peptides and the skin immune defense system
    • Schauber, J., Gallo, R. L. Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol. 122, 261-266, doi: http://dx.doi.org/10.1016/j.jaci.2008.03.027 (2008).
    • (2008) J. Allergy Clin. Immunol. , vol.122 , pp. 261-266
    • Schauber, J.1    Gallo, R.L.2
  • 6
    • 84877849172 scopus 로고    scopus 로고
    • Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens
    • Deslouches, B. et al. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrob. Agents Chemother. 57, 2511-2521, doi: 10.1128/AAC.02218-12 (2013).
    • (2013) Antimicrob. Agents Chemother. , vol.57 , pp. 2511-2521
    • Deslouches, B.1
  • 7
    • 84888439590 scopus 로고    scopus 로고
    • Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic betasheet forming peptide amphiphiles
    • Ong, Z. Y. et al. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic betasheet forming peptide amphiphiles. Biomaterials 35, 1315-1325, doi: 10.1016/j.biomaterials.2013.10.053 (2014).
    • (2014) Biomaterials , vol.35 , pp. 1315-1325
    • Ong, Z.Y.1
  • 8
    • 33144454355 scopus 로고    scopus 로고
    • Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections
    • King, M. D. et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144, 309-317 (2006).
    • (2006) Ann Intern Med , vol.144 , pp. 309-317
    • King, M.D.1
  • 9
    • 84896712720 scopus 로고    scopus 로고
    • Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States
    • Limbago, B. M. et al. Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States. Journal of clinical microbiology 52, 998-1002, doi: 10.1128/JCM.02187-13 (2014).
    • (2014) Journal of Clinical Microbiology , vol.52 , pp. 998-1002
    • Limbago, B.M.1
  • 10
    • 0035936156 scopus 로고    scopus 로고
    • Innate antimicrobial peptide protects the skin from invasive bacterial infection
    • Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457, doi: 10.1038/35106587 (2001).
    • (2001) Nature , vol.414 , pp. 454-457
    • Nizet, V.1
  • 11
    • 44449129941 scopus 로고    scopus 로고
    • Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus
    • Ouhara, K. et al. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. The Journal of antimicrobial chemotherapy 61, 1266-1269, doi: 10.1093/jac/dkn106 (2008).
    • (2008) The Journal of Antimicrobial Chemotherapy , vol.61 , pp. 1266-1269
    • Ouhara, K.1
  • 12
    • 0036532403 scopus 로고    scopus 로고
    • How do bacteria resist human antimicrobial peptides
    • Peschel, A. How do bacteria resist human antimicrobial peptides? Trends in microbiology 10, 179-186 (2002).
    • (2002) Trends in Microbiology , vol.10 , pp. 179-186
    • Peschel, A.1
  • 13
    • 0032942727 scopus 로고    scopus 로고
    • In vitro antibacterial properties of pexiganan, an analog of magainin
    • Ge, Y. et al. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43, 782-788 (1999).
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 782-788
    • Ge, Y.1
  • 14
    • 84923234075 scopus 로고    scopus 로고
    • In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms
    • Flamm, R. K. et al. In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms. Antimicrob. Agents Chemother. 59, 1751-1754, doi: 10.1128/AAC.04773-14 (2015).
    • (2015) Antimicrob. Agents Chemother. , vol.59 , pp. 1751-1754
    • Flamm, R.K.1
  • 15
    • 23044472373 scopus 로고    scopus 로고
    • Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: Implications for systemic applications
    • Deslouches, B. et al. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob. Agents Chemother. 49, 3208-3216, doi: 10.1128/aac.49.8.3208-3216.2005 (2005).
    • (2005) Antimicrob. Agents Chemother. , vol.49 , pp. 3208-3216
    • Deslouches, B.1
  • 16
    • 33748988741 scopus 로고    scopus 로고
    • Tryptophan-and arginine-rich antimicrobial peptides: Structures and mechanisms of action
    • Chan, D. I., Prenner, E. J., Vogel, H. J. Tryptophan-and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochimica et biophysica acta 1758, 1184-1202, doi: 10.1016/j.bbamem.2006.04.006 (2006).
    • (2006) Biochimica et Biophysica Acta , vol.1758 , pp. 1184-1202
    • Chan, D.I.1    Prenner, E.J.2    Vogel, H.J.3
  • 17
    • 84880318497 scopus 로고    scopus 로고
    • Boosting salt resistance of short antimicrobial peptides
    • Chu, H. L. et al. Boosting salt resistance of short antimicrobial peptides. Antimicrob. Agents Chemother. 57, 4050-4052, doi: 10.1128/AAC.00252-13 (2013).
    • (2013) Antimicrob. Agents Chemother. , vol.57 , pp. 4050-4052
    • Chu, H.L.1
  • 18
    • 0031686776 scopus 로고    scopus 로고
    • Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
    • Turner, J., Cho, Y., Dinh, N. N., Waring, A. J., Lehrer, R. I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214 (1998).
    • (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 2206-2214
    • Turner, J.1    Cho, Y.2    Dinh, N.N.3    Waring, A.J.4    Lehrer, R.I.5
  • 20
    • 4444316131 scopus 로고    scopus 로고
    • The advantage of bactericidal drugs in the treatment of infection
    • Alder, J., Eisenstein, B. The Advantage of Bactericidal Drugs in the Treatment of Infection. Curr. Infect. Dis. Rep. 6, 251-253 (2004).
    • (2004) Curr. Infect. Dis. Rep. , vol.6 , pp. 251-253
    • Alder, J.1    Eisenstein, B.2
  • 21
    • 84908227247 scopus 로고    scopus 로고
    • Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. Aureus disease
    • Conlon, B. P. Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease. BioEssays: news and reviews in molecular, cellular and developmental biology 36, 991-996, doi: 10.1002/bies.201400080 (2014).
    • (2014) BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology , vol.36 , pp. 991-996
    • Conlon, B.P.1
  • 23
    • 77955628762 scopus 로고    scopus 로고
    • Persister cells
    • Lewis, K. Persister cells. Annual review of microbiology 64, 357-372, doi: 10.1146/annurev.micro.112408.134306 (2010).
    • (2010) Annual Review of Microbiology , vol.64 , pp. 357-372
    • Lewis, K.1
  • 24
    • 33845607284 scopus 로고    scopus 로고
    • Persister cells, dormancy and infectious disease
    • Lewis, K. Persister cells, dormancy and infectious disease. Nature reviews. Microbiology 5, 48-56, doi: 10.1038/nrmicro1557 (2007).
    • (2007) Nature Reviews. Microbiology , vol.5 , pp. 48-56
    • Lewis, K.1
  • 25
    • 84888019629 scopus 로고    scopus 로고
    • Activated ClpP kills persisters and eradicates a chronic biofilm infection
    • Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503, 365-370, doi: 10.1038/nature12790 (2013).
    • (2013) Nature , vol.503 , pp. 365-370
    • Conlon, B.P.1
  • 27
    • 78650293305 scopus 로고    scopus 로고
    • Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections
    • Hurdle, J. G., O'Neill, A. J., Chopra, I., Lee, R. E. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nature reviews. Microbiology 9, 62-75, doi: 10.1038/nrmicro2474 (2011).
    • (2011) Nature Reviews. Microbiology , vol.9 , pp. 62-75
    • Hurdle, J.G.1    O'Neill, A.J.2    Chopra, I.3    Lee, R.E.4
  • 28
    • 80053910254 scopus 로고    scopus 로고
    • Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
    • Archer, N. K. et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2, 445-459, doi: 10.4161/viru.2.5.17724 (2011).
    • (2011) Virulence , vol.2 , pp. 445-459
    • Archer, N.K.1
  • 29
    • 0035014383 scopus 로고    scopus 로고
    • Mechanisms of biofilm resistance to antimicrobial agents
    • Mah, T. F., O'Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. Trends in microbiology 9, 34-39 (2001).
    • (2001) Trends in Microbiology , vol.9 , pp. 34-39
    • Mah, T.F.1    O'Toole, G.A.2
  • 30
    • 77958021478 scopus 로고    scopus 로고
    • Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window
    • Wolcott, R. D. et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. Journal of wound care 19, 320-328, doi: 10.12968/jowc.2010.19.8.77709 (2010).
    • (2010) Journal of Wound Care , vol.19 , pp. 320-328
    • Wolcott, R.D.1
  • 31
    • 0020043039 scopus 로고
    • Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis
    • Christensen, G. D. et al. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Annals of internal medicine 96, 1-10 (1982).
    • (1982) Annals of Internal Medicine , vol.96 , pp. 1-10
    • Christensen, G.D.1
  • 32
    • 77955593345 scopus 로고    scopus 로고
    • Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms
    • Singh, R., Ray, P., Das, A., Sharma, M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. The Journal of antimicrobial chemotherapy 65, 1955-1958, doi: 10.1093/jac/dkq257 (2010).
    • (2010) The Journal of Antimicrobial Chemotherapy , vol.65 , pp. 1955-1958
    • Singh, R.1    Ray, P.2    Das, A.3    Sharma, M.4
  • 33
    • 79956219045 scopus 로고    scopus 로고
    • Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus
    • Dean, S. N., Bishop, B. M., van Hoek, M. L. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC microbiology 11, 114, doi: 10.1186/1471-2180-11-114 (2011).
    • (2011) BMC Microbiology , vol.11 , pp. 114
    • Dean, S.N.1    Bishop, B.M.2    Van Hoek, M.L.3
  • 34
    • 77950345996 scopus 로고    scopus 로고
    • Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: Is combination therapy the answer
    • Nguyen, H. M., Graber, C. J. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? J. Antimicrob. Chemother. 65, 24-36, doi: 10.1093/jac/dkp377 (2010).
    • (2010) J. Antimicrob. Chemother. , vol.65 , pp. 24-36
    • Nguyen, H.M.1    Graber, C.J.2
  • 35
    • 84951130723 scopus 로고    scopus 로고
    • Antibacterial evaluation of synthetic thiazole compounds in vitro and in vivo in a methicillin-resistant staphylococcus aureus (MRSA) skin infection mouse model
    • Mohammad, H., Cushman, M., Seleem, M. N. Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model. PloS one 10, e0142321, doi: 10.1371/journal. pone.0142321 (2015).
    • (2015) PloS One , vol.10 , pp. e0142321
    • Mohammad, H.1    Cushman, M.2    Seleem, M.N.3
  • 36
    • 84865056525 scopus 로고    scopus 로고
    • The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents
    • Marks, L. R., Clementi, E. A., Hakansson, A. P. The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents. PloS one 7, e43514, doi: 10.1371/journal.pone.0043514 (2012).
    • (2012) PloS One , vol.7 , pp. e43514
    • Marks, L.R.1    Clementi, E.A.2    Hakansson, A.P.3
  • 37
    • 84877032645 scopus 로고    scopus 로고
    • Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET
    • Marks, L. R., Clementi, E. A., Hakansson, A. P. Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET. PloS one 8, e63158, doi: 10.1371/journal.pone.0063158 (2013).
    • (2013) PloS One , vol.8 , pp. e63158
    • Marks, L.R.1    Clementi, E.A.2    Hakansson, A.P.3
  • 38
    • 1242307761 scopus 로고    scopus 로고
    • Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35
    • Minahk, C. J., Dupuy, F., Morero, R. D. Enhancement of antibiotic activity by sub-lethal concentrations of enterocin CRL35. The Journal of antimicrobial chemotherapy 53, 240-246, doi: 10.1093/jac/dkh079 (2004).
    • (2004) The Journal of Antimicrobial Chemotherapy , vol.53 , pp. 240-246
    • Minahk, C.J.1    Dupuy, F.2    Morero, R.D.3
  • 39
    • 70349238995 scopus 로고    scopus 로고
    • Esculentin-1b(1-18)-a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli
    • Marcellini, L. et al. Esculentin-1b(1-18)-a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. The FEBS journal 276, 5647-5664, doi: 10.1111/j.1742-4658.2009. 07257.x (2009).
    • (2009) The FEBS Journal , vol.276 , pp. 5647-5664
    • Marcellini, L.1
  • 41
    • 33644850786 scopus 로고    scopus 로고
    • Intracellular Staphylococcus aureus and antibiotic resistance: Implications for treatment of staphylococcal osteomyelitis
    • Ellington, J. K. et al. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 24, 87-93, doi: 10.1002/jor.20003 (2006).
    • (2006) Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society , vol.24 , pp. 87-93
    • Ellington, J.K.1
  • 42
    • 0029803527 scopus 로고    scopus 로고
    • Penetration of vancomycin into human lung tissue
    • Cruciani, M. et al. Penetration of vancomycin into human lung tissue. J. Antimicrob. Chemother. 38, 865-869 (1996).
    • (1996) J. Antimicrob. Chemother. , vol.38 , pp. 865-869
    • Cruciani, M.1
  • 44
    • 0035370730 scopus 로고    scopus 로고
    • Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: A cause for antibiotic treatment failure in a patient with darier's disease
    • von Eiff, C. et al. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 32, 1643-1647, doi: 10.1086/320519 (2001).
    • (2001) Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America , vol.32 , pp. 1643-1647
    • Von Eiff, C.1
  • 45
    • 84908296966 scopus 로고    scopus 로고
    • Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection
    • Mohamed, M. F., Seleem, M. N. Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection. Drug design, development and therapy 8, 1979-1983, doi: 10.2147/DDDT.S72129 (2014).
    • (2014) Drug Design, Development and Therapy , vol.8 , pp. 1979-1983
    • Mohamed, M.F.1    Seleem, M.N.2
  • 46
    • 84933054771 scopus 로고    scopus 로고
    • Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
    • Thangamani, S., Younis, W., Seleem, M. N. Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections. Scientific reports 5, 11596, doi: 10.1038/srep11596 (2015).
    • (2015) Scientific Reports , vol.5 , pp. 11596
    • Thangamani, S.1    Younis, W.2    Seleem, M.N.3
  • 48
    • 84938850641 scopus 로고    scopus 로고
    • Repurposing celecoxib as a topical antimicrobial agent
    • Thangamani, S., Younis, W., Seleem, M. N. Repurposing celecoxib as a topical antimicrobial agent. Frontiers in microbiology 6, 750, doi: 10.3389/fmicb.2015.00750 (2015).
    • (2015) Frontiers in Microbiology , vol.6 , pp. 750
    • Thangamani, S.1    Younis, W.2    Seleem, M.N.3
  • 49
    • 84946950123 scopus 로고    scopus 로고
    • Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
    • Thangamani, S. et al. Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent. Scientific reports 5, 16407, doi: 10.1038/srep16407 (2015).
    • (2015) Scientific Reports , vol.5 , pp. 16407
    • Thangamani, S.1
  • 50
    • 33847020833 scopus 로고    scopus 로고
    • Inflammation in wound repair: Molecular and cellular mechanisms
    • Eming, S. A., Krieg, T., Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. The Journal of investigative dermatology 127, 514-525, doi: 10.1038/sj.jid.5700701 (2007).
    • (2007) The Journal of Investigative Dermatology , vol.127 , pp. 514-525
    • Eming, S.A.1    Krieg, T.2    Davidson, J.M.3
  • 51
    • 84879816895 scopus 로고    scopus 로고
    • Local inflammation exacerbates the severity of Staphylococcus aureus skin infection
    • Montgomery, C. P. et al. Local inflammation exacerbates the severity of Staphylococcus aureus skin infection. PloS one 8, e69508, doi: 10.1371/journal.pone.0069508 (2013).
    • (2013) PloS One , vol.8 , pp. e69508
    • Montgomery, C.P.1
  • 52
    • 79960845616 scopus 로고    scopus 로고
    • Immunity against Staphylococcus aureus cutaneous infections
    • Miller, L. S., Cho, J. S. Immunity against Staphylococcus aureus cutaneous infections. Nat. Rev. Immunol. 11, 505-518, doi: 10.1038/nri3010 (2011).
    • (2011) Nat. Rev. Immunol. , vol.11 , pp. 505-518
    • Miller, L.S.1    Cho, J.S.2
  • 54
    • 56749150574 scopus 로고    scopus 로고
    • Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: A randomized, controlled, double-blinded, multicenter trial of pexiganan cream
    • Lipsky, B. A., Holroyd, K. J., Zasloff, M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 47, 1537-1545, doi: 10.1086/593185 (2008).
    • (2008) Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America , vol.47 , pp. 1537-1545
    • Lipsky, B.A.1    Holroyd, K.J.2    Zasloff, M.3
  • 55
    • 84954348442 scopus 로고    scopus 로고
    • Investigational drugs to treat methicillin-resistant Staphylococcus aureus
    • Vuong, C., Yeh, A. J., Cheung, G. Y., Otto, M. Investigational drugs to treat methicillin-resistant Staphylococcus aureus. Expert opinion on investigational drugs, 1-21, doi: 10.1517/13543784.2016.1109077 (2015).
    • (2015) Expert Opinion on Investigational Drugs , pp. 1-21
    • Vuong, C.1    Yeh, A.J.2    Cheung, G.Y.3    Otto, M.4
  • 57
    • 84903138381 scopus 로고    scopus 로고
    • Targeting methicillin-resistant Staphylococcus aureus with short saltresistant synthetic peptides
    • Mohamed, M. F., Hamed, M. I., Panitch, A., Seleem, M. N. Targeting methicillin-resistant Staphylococcus aureus with short saltresistant synthetic peptides. Antimicrobial agents and chemotherapy 58, 4113-4122, doi: 10.1128/AAC.02578-14 (2014).
    • (2014) Antimicrobial Agents and Chemotherapy , vol.58 , pp. 4113-4122
    • Mohamed, M.F.1    Hamed, M.I.2    Panitch, A.3    Seleem, M.N.4
  • 58
    • 84960155188 scopus 로고    scopus 로고
    • Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
    • Thangamani, S. et al. Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Scientific reports 6, 22571, doi: 10.1038/srep22571 (2016).
    • (2016) Scientific Reports , vol.6 , pp. 22571
    • Thangamani, S.1
  • 59
    • 84928781973 scopus 로고    scopus 로고
    • Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci
    • Mohammad, H., Mayhoub, A. S., Cushman, M., Seleem, M. N. Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci. The Journal of antibiotics 68, 259-266, doi: 10.1038/ja.2014.142 (2015).
    • (2015) The Journal of Antibiotics , vol.68 , pp. 259-266
    • Mohammad, H.1    Mayhoub, A.S.2    Cushman, M.3    Seleem, M.N.4
  • 60
    • 85014202598 scopus 로고    scopus 로고
    • Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs
    • Mohamed, M. F., Hammac, G. K., Guptill, L., Seleem, M. N. Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs. PloS one 9, e116259, doi: 10.1371/journal. pone.0116259 (2014).
    • (2014) PloS One , vol.9 , pp. e116259
    • Mohamed, M.F.1    Hammac, G.K.2    Guptill, L.3    Seleem, M.N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.